Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 2023-11-22 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 2024-06-13 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 2020-12-31 | |
| Chairman | 70 | 2020-12-31 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| -0.62% | -1.87% | +42.87% | +67.17% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +73.89% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +102.20% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +48.51% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +104.26% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +840.10% | 41B | |
| +3.27% | +47.96% | +112.84% | +91.02% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +47.05% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +350.50% | 24.7B | |
| Average | +0.60% | +7.54% | +47.58% | +191.63% | 43.82B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +173.41% |
Employees
4
